Erratum: Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer (Annals of Surgical Oncology (2011) 18 (1122-1129)DOI: 10.1245/S10434-010-1401-9)
暂无分享,去创建一个
A. Moser | H. Zeh | D. Bartlett | B. Lembersky | N. Bahary | Kenneth K. Lee | S. Hughes | P. Bao | R. Ramanathan | A. Krasinkas